These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Relationship between Oxidative Stress, Inflammation and Dyslipidemia with Fatty Liver Index in Patients with Type 2 Diabetes Mellitus. Klisic A; Isakovic A; Kocic G; Kavaric N; Jovanovic M; Zvrko E; Skerovic V; Ninic A Exp Clin Endocrinol Diabetes; 2018 Jun; 126(6):371-378. PubMed ID: 28895641 [TBL] [Abstract][Full Text] [Related]
3. Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients. Świderska M; Maciejczyk M; Zalewska A; Pogorzelska J; Flisiak R; Chabowski A Free Radic Res; 2019 Aug; 53(8):841-850. PubMed ID: 31234658 [TBL] [Abstract][Full Text] [Related]
4. Advanced oxidation protein products, total thiol levels and total oxidant/antioxidant status in patients with nash. Başkol M; Dolbun Seçkin K; Başkol G Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():32-7. PubMed ID: 25910362 [TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic Fatty Liver Disease Severity Is Related to Plasma Pro-Oxidative Biomarkers Rather Than Liver Tissue-Measured Nitrogen Metabolism Biomarkers in Population with Obesity and Metabolic Syndrome. Suárez-Cuenca JA; Domínguez-Pérez GA; Hernández-Muñóz RE; Hernández-Patricio A; Vera-Gómez E; Gutiérrez-Buendía JA; Salamanca-García M; Montoya-Ramírez J; Gaytán-Fuentes OF; Aranda-Rodríguez C; Rojas-Noverón AR; García S; Mondragón-Terán P Metab Syndr Relat Disord; 2023 Mar; 21(2):115-121. PubMed ID: 36787445 [No Abstract] [Full Text] [Related]
6. Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents. Torun E; Gökçe S; Ozgen İT; Aydın S; Cesur Y J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):667-75. PubMed ID: 24706428 [TBL] [Abstract][Full Text] [Related]
7. Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease. Pirgon Ö; Bilgin H; Çekmez F; Kurku H; Dündar BN J Clin Res Pediatr Endocrinol; 2013; 5(1):33-9. PubMed ID: 23367495 [TBL] [Abstract][Full Text] [Related]
8. Principal component analysis of the oxidative stress, inflammation, and dyslipidemia influence in patients with different levels of glucoregulation. Malenica M; Klisić A; Meseldžić N; Dujić T; Bego T; Kotur-Stevuljević J J Med Biochem; 2023 Aug; 42(3):427-436. PubMed ID: 37814622 [TBL] [Abstract][Full Text] [Related]
9. Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea. Erdogan HK; Bulur I; Kocaturk E; Saracoglu ZN; Alatas O; Bilgin M Postepy Dermatol Alergol; 2018 Jun; 35(3):304-308. PubMed ID: 30008650 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of the Omega-3 Index in predicting non-alcoholic fatty liver disease in overweight and obese adults: a pilot study. Parker HM; O'Connor HT; Keating SE; Cohn JS; Garg ML; Caterson ID; George J; Johnson NA Br J Nutr; 2015 Sep; 114(5):780-7. PubMed ID: 26202539 [TBL] [Abstract][Full Text] [Related]
11. Factorial Analysis of the Cardiometabolic Risk Influence on Redox Status Components in Adult Population. Klisic A; Kavaric N; Vujcic S; Spasojevic-Kalimanovska V; Kotur-Stevuljevic J; Ninic A Oxid Med Cell Longev; 2021; 2021():6661940. PubMed ID: 33936384 [TBL] [Abstract][Full Text] [Related]
12. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound. Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896 [TBL] [Abstract][Full Text] [Related]
14. Pro- and prebiotic effects on oxidative stress and inflammatory markers in non-alcoholic fatty liver disease. Javadi L; Khoshbaten M; Safaiyan A; Ghavami M; Abbasi MM; Gargari BP Asia Pac J Clin Nutr; 2018; 27(5):1031-1039. PubMed ID: 30272851 [TBL] [Abstract][Full Text] [Related]
15. New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress. Ferro D; Baratta F; Pastori D; Cocomello N; Colantoni A; Angelico F; Del Ben M Nutrients; 2020 Sep; 12(9):. PubMed ID: 32927776 [TBL] [Abstract][Full Text] [Related]
16. Serum levels of nitrate, nitrite and advanced oxidation protein products (AOPP) in patients with nonalcoholic fatty liver disease. Çiftci A; Yilmaz B; Köklü S; Yüksel O; Özsoy M; Erden G; Öztürk G; Akbal E; Ergül B; Koçak E; Cesur S Acta Gastroenterol Belg; 2015 Jun; 78(2):201-5. PubMed ID: 26151688 [TBL] [Abstract][Full Text] [Related]
17. Oxidative stress in lung cancer patients is associated with altered serum markers of lipid metabolism. Zabłocka-Słowińska K; Płaczkowska S; Skórska K; Prescha A; Pawełczyk K; Porębska I; Kosacka M; Grajeta H PLoS One; 2019; 14(4):e0215246. PubMed ID: 30973911 [TBL] [Abstract][Full Text] [Related]
18. Pro-oxidant antioxidant balance in patients with non-alcoholic fatty liver disease. Nobakht Motlagh Ghoochani BF; Ghafourpour M; Abdollahi F; Tavallaie S Gastroenterol Hepatol Bed Bench; 2019; 12(2):124-130. PubMed ID: 31191836 [TBL] [Abstract][Full Text] [Related]
19. Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults. Liu Y; Wang W Lipids Health Dis; 2022 Jan; 21(1):8. PubMed ID: 35027066 [TBL] [Abstract][Full Text] [Related]
20. Serum Levels of Oxidative Stress Markers in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Steatohepatitis. Casoinic F; Sampelean D; Buzoianu AD; Hancu N; Baston D Rom J Intern Med; 2016 Dec; 54(4):228-236. PubMed ID: 28002036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]